课题基金 / 基金详情

Development of a novel therapy for hormone-refractory prostate cancer

Development of a novel therapy for hormone-refractory prostate cancer
开发激素难治性前列腺癌的新疗法
批准号:
17591679
负责人:
MATSUBARA Akio
金额:
$2.37万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2005
资助国家:
日本
项目状态:
已结题
起止时间:
2005 至 2006

项目摘要

项目成果

MATSUBARA Akio的其他基金

相似基金

相关文献

中文摘要
翻译
研究结果成纤维细胞生长因子受体2(FGFR2)是一种受体型酪氨酸激酶,对激素非依赖性前列腺癌具有生长抑制作用。为了研究辐射和抗癌剂与FGFR2在激素非依赖性人前列腺癌细胞中的协同作用,将FGFR2基因导入激素非依赖性人前列腺癌细胞系PC3。分别用流式细胞仪和膜联蛋白亲和分析检测放射或多西紫杉醇对PC3细胞周期和细胞凋亡的影响。FGFR2在PC3细胞中的表达导致体外生长抑制和体内肿瘤形成,同时增加细胞分化和凋亡。4~8Gy射线照射后,PC3细胞的集落数进一步减少。Annexin亲和分析表明,8Gy射线照射后PC3细胞发生明显的细胞凋亡。8Gy射线照射后24小时,PC3细胞的G2/M期比例明显高于Mock细胞。多西紫杉醇对PC3细胞也有类似的作用。这些结果表明,放射和多西紫杉醇增强了FGFR2在激素耐药的人前列腺癌细胞中的生长抑制活性。FGFR2联合放疗或多西紫杉醇可能为激素耐药前列腺癌的基因治疗提供新的途径。
英文摘要
RESEARCH RESULTS Fibroblast growth factor receptor 2 (FGFR2) is a receptor-type tyrosine kinase that has a growth inhibitory effect on hormone-refractory prostate cancer. To investigate the synergistic effects of radiation and an anticancer agent with FGFR2 in hormone-refractory human prostate cancer cells, a hormone-refractory human prostate cancer cell line, PC3, was transfected with FGFR2. The effects of radiation or docetaxel on cell cycle and apoptosis were evaluated by flowcytometry and Annexin affinity assay, respectively.Expression of FGFR2 in PC3 cells resulted in growth suppression in vitro and reduced tumor formation in vivo concurrent with increased cellular differentiation and apoptosis. Four to 8 Gy of radiation further decreased the number of colonies in transfected PC3 cells. Annexin affinity assay revealed that 8 Gy of radiation caused significant apoptosis for transfected PC3 cells. Also, at 24 hours after 8 Gy of radiation, proportion of G2/M phase was significantly higher in the transfected PC3 cells than in Mock cell. Docetaxel showed similar effects on the transfected PC3 cells.These results indicate that radiation and docetaxel enhance the growth-suppressive activity of FGFR2 in hormone-refractory human prostate cancer cells. Combination of FGFR2 with radiation or docetaxel may provide a new avenue for gene therapy of hormone-refractory prostate cancer.
期刊论文(13)
专著(0)
科研奖励(0)
会议论文
前立腺癌検診におけるAge-specific Reference Range of PSAの有用性
PSA 年龄特异性参考范围在前列腺癌筛查中的作用
DOI: --
发表时间: 2005
期刊: 臨床泌尿器科 18・8
影响因子: --
作者: [Furuya, Nagakawa, Fuse et al., Yoshimasa Ishida, Yasuhisa Hasegawa, Yasuhisa Hasegawa, 松原昭郎, 亭島淳, Akio Matsubara, Jun Teishima, 亭島淳, Shunichi Namiki, 松原昭郎, Akio Matsubara, 松原昭郎, 石光広]
通讯作者: 石光広
DOI: --
发表时间: 2006
期刊: 日本内分泌学会雑誌 82・2
影响因子: --
作者: [Furuya, Nagakawa, Fuse et al., Yoshimasa Ishida, Yasuhisa Hasegawa, Yasuhisa Hasegawa, 松原昭郎]
通讯作者: 松原昭郎
Changes in quality of life in first year after radical prostatectomy by retropubic, Laparoscopic and perineal approach : Malti- institutional longitudinal study in Japan
耻骨后、腹腔镜和会阴入路根治性前列腺切除术后第一年生活质量的变化:日本马耳他机构纵向研究
DOI: --
发表时间: 2006
期刊: Urology 67・2
影响因子: --
作者: [Furuya, Nagakawa, Fuse et al., Yoshimasa Ishida, Yasuhisa Hasegawa, Yasuhisa Hasegawa, 松原昭郎, 亭島淳, Akio Matsubara, Jun Teishima, 亭島淳, Shunichi Namiki]
通讯作者: Shunichi Namiki
総説 会陰式前立腺全摘除術
审查会阴根治性前列腺切除术
DOI: --
发表时间: 2005
期刊: 西日本泌尿器科 67・7
影响因子: --
作者: [Furuya, Nagakawa, Fuse et al., Yoshimasa Ishida, Yasuhisa Hasegawa, Yasuhisa Hasegawa, 松原昭郎, 亭島淳, Akio Matsubara, Jun Teishima, 亭島淳, Shunichi Namiki, 松原昭郎, Akio Matsubara, 松原昭郎]
通讯作者: 松原昭郎
共 12 条
    Identification and clinical application of novel biomarkers for neuroendocrine differentiation of prostate cancer
    • 批准号:
      24592391
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.41万
    • 财政年份:
      2012
    • 负责人:
      MATSUBARA Akio
    • 依托单位:
    Identification and translational research of transmenbrane and secretary proteins in prostate cancer
    • 批准号:
      21592046
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.0万
    • 财政年份:
      2009
    • 负责人:
      MATSUBARA Akio
    • 依托单位:
    Implication of FGFR in loss of hormone dependency of prostate cancer and its application to new therapy for prostate cancer
    • 批准号:
      19591852
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.83万
    • 财政年份:
      2007
    • 负责人:
      MATSUBARA Akio
    • 依托单位:
    FGFR2 gene mutation in human prostate cancer : Close relation to loss of hormone dependency and therapeutic application
    • 批准号:
      15591690
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.24万
    • 财政年份:
      2003
    • 负责人:
      MATSUBARA Akio
    • 依托单位:
    海外基金